Recent trends in protein and peptide-based biomaterials for advanced drug delivery

Petrak, 2005, Essential properties of drug-targeting delivery systems, Drug Discov. Today, 10, 1667, 10.1016/S1359-6446(05)03698-6 Fenton, 2018, Advances in biomaterials for drug delivery, Adv. Mater., 30, 1705328, 10.1002/adma.201705328 Li, 2019, Recent progress in drug delivery, Acta Pharm. Sin. B, 9, 1145, 10.1016/j.apsb.2019.08.003 Tong, 2020, Recent advances in natural polymer-based drug delivery systems, React. Funct. Polym., 148, 104501, 10.1016/j.reactfunctpolym.2020.104501 Jao, 2017, Protein-based drug-delivery materials, Materials (Basel), 10, 10.3390/ma10050517 Abascal, 2018, The past, present and future of protein-based materials, Open Biol., 8, 10.1098/rsob.180113 Saha, 2020, Engineering the architecture of elastin-like polypeptides: from Unimers to hierarchical self-assembly, Adv. Ther., 3, 1900164, 10.1002/adtp.201900164 Elzoghby, 2012, Protein-based nanocarriers as promising drug and gene delivery systems, J. Control. Release, 161, 38, 10.1016/j.jconrel.2012.04.036 Strebhardt, 2008, Paul Ehrlich's magic bullet concept: 100 years of progress, Nat. Rev. Cancer, 8, 473, 10.1038/nrc2394 Yun, 2015, Controlled drug delivery: historical perspective for the next generation, J. Control. Release, 219, 2, 10.1016/j.jconrel.2015.10.005 Hoffman, 2008, The origins and evolution of “controlled” drug delivery systems, J. Control. Release, 132, 153, 10.1016/j.jconrel.2008.08.012 Park, 2014, Controlled drug delivery systems: past forward and future back, J. Control. Release, 190, 3, 10.1016/j.jconrel.2014.03.054 Zhang, 2013, Advanced materials and processing for drug delivery: the past and the future, Adv. Drug Deliv. Rev., 65, 104, 10.1016/j.addr.2012.10.003 Rosen, 2005, The rise and rise of drug delivery, Nat. Rev. Drug Discov., 4, 381, 10.1038/nrd1721 Uhrich, 1999, Polymeric Systems for Controlled Drug Release, Chem. Rev., 99, 3181, 10.1021/cr940351u Ekladious, 2019, Polymer–drug conjugate therapeutics: advances, insights and prospects, Nat. Rev. Drug Discov., 18, 273, 10.1038/s41573-018-0005-0 Simone, 2008, Polymeric carriers: role of geometry in drug delivery, Expert Opin. Drug Deliv., 5, 1283, 10.1517/17425240802567846 Hickey, 2015, Control of polymeric nanoparticle size to improve therapeutic delivery, J. Control. Release, 219, 536, 10.1016/j.jconrel.2015.10.006 Hamid Akash, 2015, Natural and synthetic polymers as drug carriers for delivery of therapeutic proteins, Polym. Rev., 55, 371, 10.1080/15583724.2014.995806 Kobsa, 2008, Bioengineering approaches to controlled protein delivery, Pediatr. Res., 63, 513, 10.1203/PDR.0b013e318165f14d Choi, 2018, 161 Boyle, 2018, Applications of de novo designed peptides, 51 Song, 2018, Current development of biodegradable polymeric materials for biomedical applications, Drug Des. Devel. Ther., 12, 3117, 10.2147/DDDT.S165440 Rodríguez Cabello, 2016, Chemical Modification of Biomaterials from Nature, Biomater. from Nat. Adv. Devices Ther, 444, 10.1002/9781119126218.ch24 Sengupta, 2010, Protein-engineered biomaterials: highly tunable tissue engineering scaffolds, Tissue Eng. Part B. Rev., 16, 285, 10.1089/ten.teb.2009.0591 Wals, 2014, Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins, Front. Chem., 2, 15, 10.3389/fchem.2014.00015 Huang, 2016, The coming of age of de novo protein design, Nature., 537, 320, 10.1038/nature19946 Hollingshead, 2017, Designing Smart Materials with Recombinant Proteins, Macromol. Biosci., 17, 10.1002/mabi.201600554 Sun, 2017, Nanostructures based on protein self-assembly: from hierarchical construction to bioinspired materials, Nano Today, 14, 16, 10.1016/j.nantod.2017.04.006 Gelderblom, 2001, Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation, Eur. J. Cancer, 37, 1590, 10.1016/S0959-8049(01)00171-X Du, 2018, Transport and interactions of nanoparticles in the kidneys, Nat. Rev. Mater., 3, 358, 10.1038/s41578-018-0038-3 Brenner, 1978, Glomerular permselectivity: Barrier function based on discrimination of molecular size and charge, Am. J. Physiol. - Ren. Fluid Electrolyte Physiol., 3 Zahr, 2006, Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol), Langmuir., 22, 8178, 10.1021/la060951b Park, 2019, Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment, Theranostics., 9, 8073, 10.7150/thno.37198 Salahpour Anarjan, 2019, Active targeting drug delivery nanocarriers: ligands, Nano Struct. Nano-Objects, 19, 100370, 10.1016/j.nanoso.2019.100370 Attia, 2019, An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites, J. Pharm. Pharmacol., 71, 1185, 10.1111/jphp.13098 Azzi, 2013, Vascular permeability and drug delivery in cancers, Front. Oncol., 3, 211, 10.3389/fonc.2013.00211 Barua, 2014, Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects, Nano Today, 9, 223, 10.1016/j.nantod.2014.04.008 Tee, 2019, Nanoparticles' interactions with vasculature in diseases, Chem. Soc. Rev., 48, 5381, 10.1039/C9CS00309F Nelemans, 2020, Drug delivery with polymeric nanocarriers-cellular uptake mechanisms, Materials (Basel), 13, 10.3390/ma13020366 Zhang, 2019, Improving cellular uptake of therapeutic entities through interaction with components of cell membrane, Drug Deliv., 26, 328, 10.1080/10717544.2019.1582730 Rajendran, 2010, Subcellular targeting strategies for drug design and delivery, Nat. Rev. Drug Discov., 9, 29, 10.1038/nrd2897 Son, 2017, Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles, J. Pharm. Investig., 47, 287, 10.1007/s40005-017-0320-1 Sertkaya, 2016, Key cost drivers of pharmaceutical clinical trials in the United States, Clin. Trials., 13, 117, 10.1177/1740774515625964 Patel, 2019, Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines, Sci. Rep., 9, 1, 10.1038/s41598-019-42456-8 Cao, 2018, The effects of ligand valency and density on the targeting ability of multivalent nanoparticles based on negatively charged chitosan nanoparticles, Colloids Surfaces B Biointerfaces., 161, 508, 10.1016/j.colsurfb.2017.11.015 Wang, 2019, Heuristics for the optimal presentation of bioactive peptides on polypeptide micelles, Nano Lett., 19, 7977, 10.1021/acs.nanolett.9b03141 Antoine, 2014, Review of collagen i hydrogels for bioengineered tissue microenvironments: characterization of mechanics, structure, and transport, Tissue Eng. - Part B Rev., 20, 683, 10.1089/ten.teb.2014.0086 Xing, 2014, Increasing mechanical strength of gelatin hydrogels by divalent metal ion removal, Sci. Rep., 4, 1, 10.1038/srep04706 Elzoghby, 2012, Albumin-based nanoparticles as potential controlled release drug delivery systems, J. Control. Release, 157, 168, 10.1016/j.jconrel.2011.07.031 Ramteke, 2008, Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori, J. Drug Target., 16, 65, 10.1080/10611860701733278 Vasconcelos, 2013, The use of keratin in biomedical applications, Curr. Drug Targets, 14, 612, 10.2174/1389450111314050010 Lammel, 2010, Controlling silk fibroin particle features for drug delivery, Biomaterials., 31, 4583, 10.1016/j.biomaterials.2010.02.024 Banskota, 2020, Genetically encoded stealth nanoparticles of a Zwitterionic polypeptide-paclitaxel conjugate have a wider therapeutic window than Abraxane in multiple tumor models, Nano Lett., 20, 2396, 10.1021/acs.nanolett.9b05094 Dzuricky, 2019, Avidity and cell uptake of integrin-targeting polypeptide micelles is strongly shape-dependent, Nano Lett., 19, 6124, 10.1021/acs.nanolett.9b02095 Mozhdehi, 2018, Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature-triggered hierarchical self-assembly, Nat. Chem., 10, 496, 10.1038/s41557-018-0005-z Lee, 2015, Controlled drug release from pharmaceutical nanocarriers, Chem. Eng. Sci., 125, 75, 10.1016/j.ces.2014.08.046 Bellucci, 2015, A noncanonical function of sortase enables site-specific conjugation of small molecules to lysine residues in proteins, Angew. Chemie - Int. Ed., 54, 441, 10.1002/anie.201408126 Yousefpour, 2019, Conjugate of doxorubicin to albumin-binding peptide outperforms Aldoxorubicin, Small., 15, 1804452, 10.1002/smll.201804452 Qi, 2013, Sortase-catalyzed initiator attachment enables high yield growth of a stealth polymer from the C terminus of a protein, Macromol. Rapid Commun., 34, 1256, 10.1002/marc.201300460 Chen, 2016, Improved variants of SrtA for site-specific conjugation on antibodies and proteins with high efficiency, Sci. Rep., 6, 1 Jastrzebska, 2015, Silk as an innovative biomaterial for cancer therapy, Reports Pract. Oncol. Radiother., 20, 87, 10.1016/j.rpor.2014.11.010 Pandey, 2020, Silk as a leading-edge biological macromolecule for improved drug delivery, J. Drug Deliv. Sci. Technol., 55, 101294, 10.1016/j.jddst.2019.101294 Mottaghitalab, 2015, Silk fibroin nanoparticle as a novel drug delivery system, J. Control. Release, 206, 161, 10.1016/j.jconrel.2015.03.020 Altman, 2003, Silk-based biomaterials, Biomaterials., 24, 401, 10.1016/S0142-9612(02)00353-8 Gil, 2014, Impact of sterilization on the enzymatic degradation and mechanical properties of silk biomaterials, Macromol. Biosci., 14, 257, 10.1002/mabi.201300321 Yucel, 2014, Silk-based biomaterials for sustained drug delivery, J. Control. Release, 190, 381, 10.1016/j.jconrel.2014.05.059 Wang, 2018, Design, fabrication, and function of silk-based nanomaterials, Adv. Funct. Mater., 28, 1805305, 10.1002/adfm.201805305 Murphy, 2009, Biomedical applications of chemically-modified silk fibroin, J. Mater. Chem., 19, 6443, 10.1039/b905802h Numata, 2010, Silk-based delivery systems of bioactive molecules, Adv. Drug Deliv. Rev., 62, 1497, 10.1016/j.addr.2010.03.009 Megeed, 2002, Genetically engineered silk-elastinlike protein polymers for controlled drug delivery, Adv. Drug Deliv. Rev., 54, 1075, 10.1016/S0169-409X(02)00063-7 Frandsen, 2012, Recombinant protein-based polymers for advanced drug delivery, Chem. Soc. Rev., 41, 2696, 10.1039/c2cs15303c Aigner, 2018, Biomedical applications of recombinant silk-based materials, Adv. Mater., 30, 1704636, 10.1002/adma.201704636 Mathur, 2010, Silk fibroin-derived nanoparticles for biomedical applications, Nanomedicine., 5, 807, 10.2217/nnm.10.51 Wang, 2010, Silk nanospheres and microspheres from silk/pva blend films for drug delivery, Biomaterials., 31, 1025, 10.1016/j.biomaterials.2009.11.002 Shi, 2012, Self-assembled silk fibroin particles: tunable size and appearance, Powder Technol., 215–216, 85, 10.1016/j.powtec.2011.09.012 Shi, 2011, Release and cellular acceptance of multiple drugs loaded silk fibroin particles, Int. J. Pharm., 420, 282, 10.1016/j.ijpharm.2011.08.051 Crivelli, 2019, Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis, Eur. J. Pharm. Biopharm., 137, 37, 10.1016/j.ejpb.2019.02.008 Yan, 2009, Biosynthesis of insulin-silk fibroin nanoparticles conjugates and in vitro evaluation of a drug delivery system, J. Nanopart. Res., 11, 1937, 10.1007/s11051-008-9549-y Numata, 2009, Bioengineered silk protein-based gene delivery systems, Biomaterials., 30, 5775, 10.1016/j.biomaterials.2009.06.028 Numata, 2010, Gene delivery mediated by recombinant silk proteins containing cationic and cell binding motifs, J. Control. Release, 146, 136, 10.1016/j.jconrel.2010.05.006 Numata, 2010, Silk-based gene carriers with cell membrane destabilizing peptides, Biomacromolecules., 11, 3189, 10.1021/bm101055m Yang, 2019, Biomineralization-inspired crystallization of manganese oxide on silk fibroin nanoparticles for in vivo MR/fluorescence imaging-assisted tri-modal therapy of cancer, Theranostics., 9, 6314, 10.7150/thno.36252 Mao, 2018, Cyclic cRGDfk peptide and Chlorin e6 functionalized silk fibroin nanoparticles for targeted drug delivery and photodynamic therapy, Biomaterials., 161, 306, 10.1016/j.biomaterials.2018.01.045 Yang, 2014, Multifunctional adhesive silk fibroin with blending of RGD-bioconjugated mussel adhesive protein, Biomacromolecules., 15, 1390, 10.1021/bm500001n Wu, 2016, Injectable and pH-responsive silk Nanofiber hydrogels for sustained anticancer drug delivery, ACS Appl. Mater. Interfaces, 8, 17118, 10.1021/acsami.6b04424 Lovett, 2015, Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics, Eur. J. Pharm. Biopharm., 95, 271, 10.1016/j.ejpb.2014.12.029 Ding, 2019, Injectable silk Nanofiber hydrogels for sustained release of Small-molecule drugs and vascularization, ACS Biomater. Sci. Eng., 5, 4077, 10.1021/acsbiomaterials.9b00621 Gong, 2012, Injectable thixotropic hydrogel comprising regenerated silk fibroin and hydroxypropylcellulose, Soft Matter, 8, 2875, 10.1039/c2sm06984a Germershaus, 2014, Deciphering the mechanism of protein interaction with silk fibroin for drug delivery systems, Biomaterials., 35, 3427, 10.1016/j.biomaterials.2013.12.083 Mao, 2017, Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model, Colloids Surfaces B Biointerfaces., 160, 704, 10.1016/j.colsurfb.2017.10.029 Wu, 2018, Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth, Int. J. Nanomed., 13, 5405, 10.2147/IJN.S166104 Gangrade, 2019, Injectable carbon nanotube impregnated silk based multifunctional hydrogel for localized targeted and on-demand anticancer drug delivery, ACS Biomater. Sci. Eng., 5, 2365, 10.1021/acsbiomaterials.9b00416 He, 2019, An injectable silk fibroin nanofiber hydrogel hybrid system for tumor upconversion luminescence imaging and photothermal therapy, New J. Chem., 43, 2213, 10.1039/C8NJ05766D Anderson, 1994, Morphology and primary crystal structure of a silk-like protein polymer synthesized by genetically engineered Escherichia coli bacteria, Biopolymers., 34, 1049, 10.1002/bip.360340808 Schacht, 2016, Foams made of engineered recombinant spider silk proteins as 3D scaffolds for cell growth, ACS Biomater. Sci. Eng., 2, 517, 10.1021/acsbiomaterials.5b00483 Dong, 2015, Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery, Eur. J. Pharm. Biopharm., 91, 82, 10.1016/j.ejpb.2015.01.018 Costa, 2018, Fibrous protein-based biomaterials (silk, keratin, elastin, and resilin proteins) for tissue regeneration and repair, 175 Numata, 2011, Biologically derived scaffolds, 524 Rouse, 2010, A review of keratin-based biomaterials for biomedical applications, Materials (Basel)., 3, 999, 10.3390/ma3020999 Vasconcelos, 2013, The use of keratin in biomedical applications, Curr. Drug Targets, 14, 612, 10.2174/1389450111314050010 Zhi, 2015, Preparation of keratin/chlorhexidine complex nanoparticles for long-term and dual stimuli-responsive release, RSC Adv., 5, 82334, 10.1039/C5RA16253J Ghaffari, 2018, Dual-sensitive hydrogel nanoparticles based on conjugated thermoresponsive copolymers and protein filaments for triggerable drug delivery, ACS Appl. Mater. Interfaces, 10, 19336, 10.1021/acsami.8b01154 Shah, 2018, The role of trypsin:chymotrypsin in tissue repair, Adv. Ther., 35, 31, 10.1007/s12325-017-0648-y Li, 2017, Preparation and characterization of DOX loaded keratin nanoparticles for pH/GSH dual responsive release, Mater. Sci. Eng. C., 73, 189, 10.1016/j.msec.2016.12.067 Li, 2018, Triple stimuli-responsive keratin nanoparticles as carriers for drug and potential nitric oxide release, Mater. Sci. Eng. C., 91, 606, 10.1016/j.msec.2018.05.073 Li, 2012, Biological stimuli responsive drug carriers based on keratin for triggerable drug delivery, J. Mater. Chem., 22, 19964, 10.1039/c2jm34136k Martella, 2018, Functionalized keratin as nanotechnology-based drug delivery system for the pharmacological treatment of osteosarcoma, Int. J. Mol. Sci., 19, 10.3390/ijms19113670 Cheng, 2018, Development of keratin nanoparticles for controlled gastric mucoadhesion and drug release, J. Nanobiotechnol., 16, 1, 10.1186/s12951-018-0353-2 Fujii, 2004, Convenient procedures for human hair protein films and properties of alkaline phosphatase incorporated in the film, Biol. Pharm. Bull., 27, 89, 10.1248/bpb.27.89 Vasconcelos, 2010, Protein matrices for improved wound healing: Elastase inhibition by a synthetic peptide model, Biomacromolecules., 11, 2213, 10.1021/bm100537b Cui, 2013, Transglutaminase-modified wool keratin film and its potential application in tissue engineering, Eng. Life Sci., 13, 149, 10.1002/elsc.201100206 Shavandi, 2017, Keratin: dissolution, extraction and biomedical application, Biomater. Sci., 5, 1699, 10.1039/C7BM00411G Saul, 2011, Keratin hydrogels support the sustained release of bioactive ciprofloxacin, J. Biomed. Mater. Res. - Part A., 98, 544, 10.1002/jbm.a.33147 Peyton, 2012, Halofuginone infused keratin hydrogel attenuates adhesions in a rodent cecal abrasion model, J. Surg. Res., 178, 545, 10.1016/j.jss.2012.07.053 Han, 2015, Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications, Acta Biomater., 23, 201, 10.1016/j.actbio.2015.05.013 Cao, 2019, Tunable keratin hydrogel based on disulfide shuffling strategy for drug delivery and tissue engineering, J. Colloid Interface Sci., 544, 121, 10.1016/j.jcis.2019.02.049 Guo, 2015, PH-sensitive keratin-based polymer hydrogel and its controllable drug-release behavior, J. Appl. Polym. Sci., 132, 1 Sun, 2016, Fabrication of dual-sensitive keratin-based polymer hydrogels and their controllable release behaviors, J. Biomater. Sci. Polym. Ed., 27, 1926, 10.1080/09205063.2016.1239955 Li, 2016, Enzymatic digestion of keratin for preparing a pH-sensitive biopolymer hydrogel, Aust. J. Chem., 69, 191, 10.1071/CH15224 Peralta Ramos, 2017, Sustainable and smart keratin hydrogel with pH-sensitive swelling and enhanced mechanical properties, Mater. Sci. Eng. C., 78, 619, 10.1016/j.msec.2017.04.120 Villanueva, 2019, Smart release of antimicrobial ZnO nanoplates from a pH-responsive keratin hydrogel, J. Colloid Interface Sci, 536, 372, 10.1016/j.jcis.2018.10.067 Carter, 1989, Three-dimensional structure of human serum albumin, Science (80-. ), 244, 1195, 10.1126/science.2727704 Sleep, 2013, Albumin as a versatile platform for drug half-life extension, Biochim. Biophys. Acta - Gen. Subj., 1830, 5526, 10.1016/j.bbagen.2013.04.023 Hoogenboezem, 2018, Harnessing albumin as a carrier for cancer therapies, Adv. Drug Deliv. Rev., 130, 73, 10.1016/j.addr.2018.07.011 Yousefpour, 2018, Genetically encoding albumin binding into chemotherapeutic-loaded polypeptide nanoparticles enhances their antitumor efficacy, Nano Lett., 18, 7784, 10.1021/acs.nanolett.8b03558 Huntington, 2001, Structure and properties of ovalbumin, J. Chromatogr. B Biomed. Sci. Appl., 756, 189, 10.1016/S0378-4347(01)00108-6 Wongsasulak, 2010, Electrospinning of food-grade nanofibers from cellulose acetate and egg albumen blends, J. Food Eng., 98, 370, 10.1016/j.jfoodeng.2010.01.014 Liu, 2008, Alginate microsphere-collagen composite hydrogel for ocular drug delivery and implantation, J. Mater. Sci. Mater. Med., 19, 3365, 10.1007/s10856-008-3486-2 Tantra, 2010, Characterisation of the de-agglomeration effects of bovine serum albumin on nanoparticles in aqueous suspension, Colloids Surfaces B Biointerfaces., 75, 275, 10.1016/j.colsurfb.2009.08.049 Hu, 2006, Binding of anti-inflammatory drug cromolyn sodium to bovine serum albumin, Int. J. Biol. Macromol., 39, 280, 10.1016/j.ijbiomac.2006.04.004 Yu, 2014, Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear, Nanoscale Res. Lett., 9, 1, 10.1186/1556-276X-9-343 Lam, 2015, Evaluation of berberine/bovine serum albumin nanoparticles for liver fibrosis therapy, Green Chem., 17, 1640, 10.1039/C4GC01815J Li, 2009, Self-assembly of ibuprofen and bovine serum albumin-dextran conjugates leading to effective loading of the drug, Langmuir., 25, 6385, 10.1021/la804288u Carter, 1994, Structure of serum albumin, Adv. Protein Chem., 45, 153, 10.1016/S0065-3233(08)60640-3 Peters, 1995 Curry, 1998, Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites, Nat. Struct. Biol., 5, 827, 10.1038/1869 Sugio, 1999, Crystal structure of human serum albumin at 2.5 Å resolution, Protein Eng. Des. Sel., 12, 439, 10.1093/protein/12.6.439 Arroyo, 2014, Human serum albumin, systemic inflammation, and cirrhosis, J. Hepatol., 61, 396, 10.1016/j.jhep.2014.04.012 Kragh-Hansen, 2002, Practical aspects of the ligand-binding and enzymatic properties of human serum albumin, Biol. Pharm. Bull., 25, 695, 10.1248/bpb.25.695 Cistola, 1991, Fatty acid distribution in systems modeling the normal and diabetic human circulation: a 13C nuclear magnetic resonance study, J. Clin. Invest., 87, 1431, 10.1172/JCI115149 Lee, 2015, Review: modifications of human serum albumin and their binding effect, Curr. Pharm. Des., 21, 1862, 10.2174/1381612821666150302115025 Knudsen Sand, 2015, Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics, Front. Immunol., 5, 682 Liu, 2016, Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy, Chem. Soc. Rev., 45, 1432, 10.1039/C5CS00158G Wang, 2020, Human serum albumin (HSA) and its applications as a drug delivery vehicle abstract, Heal. Sci. J., 14, 1 Liu, 2012, The reactivity of human serum albumin toward trans-4-hydroxy-2-nonenal, J. Mass Spectrom., 47, 411, 10.1002/jms.2037 Walker, 1976, Lysine residue 199 of human serum albumin is modified by acetylsalicylic acid, FEBS Lett., 66, 173, 10.1016/0014-5793(76)80496-6 Turell, 2013, The thiol pool in human plasma: the central contribution of albumin to redox processes, Free Radic. Biol. Med., 65, 244, 10.1016/j.freeradbiomed.2013.05.050 Schnitzer, 1992, gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis, Am. J. Physiol. - Hear. Circ. Physiol, 262 Schnitzer, 1994, Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins, J. Biol. Chem., 269, 6072, 10.1016/S0021-9258(17)37571-3 Komiya, 2016, SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer, Onco. Targets. Ther., 9, 6663, 10.2147/OTT.S114492 Gong, 2018, Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas, Drug Des. Devel. Ther., 12, 777, 10.2147/DDDT.S140638 Lau, 2015, Discovery of the once-weekly glucagon-like Peptide-1 (GLP-1) analogue Semaglutide, J. Med. Chem., 58, 7370, 10.1021/acs.jmedchem.5b00726 Hall, 2018, Pharmacokinetics and clinical implications of Semaglutide: a new glucagon-like peptide (GLP)-1 receptor agonist, Clin. Pharmacokinet., 57, 1529, 10.1007/s40262-018-0668-z Keith, 1915, A method for the determination of plasma and blood volume, Arch. Intern. Med. XVI, 547, 10.1001/archinte.1915.00080040043004 de Goldim, 2019, Using Evans Blue Dye to Determine Blood-Brain Barrier Integrity in Rodents, Curr. Protoc. Immunol., 126, 10.1002/cpim.83 Jacobson, 2016, Albumin-binding Evans blue derivatives for diagnostic imaging and production of long-acting therapeutics, Bioconjug. Chem., 27, 2239, 10.1021/acs.bioconjchem.6b00487 Yamamoto, 2004, First functionalized MRI contrast agent recognizing vascular lesions, Anal. Sci., 20, 5, 10.2116/analsci.20.5 Niu, 2014, In vivo labeling of serum albumin for PET, J. Nucl. Med., 55, 1150, 10.2967/jnumed.114.139642 Wang, 2015, In vivo albumin labeling and lymphatic imaging, Proc. Natl. Acad. Sci. U. S. A., 112, 208, 10.1073/pnas.1414821112 Zang, 2020, Combined 68Ga-NOTA-Evans blue Lymphoscintigraphy and 68Ga-NOTA-RM26 PET/CT evaluation of sentinel lymph node metastasis in breast Cancer patients, Bioconjug. Chem., 31, 396, 10.1021/acs.bioconjchem.9b00789 Dumelin, 2008, A portable albumin binder from a DNA-encoded chemical library, Angew. Chemie - Int. Ed., 47, 3196, 10.1002/anie.200704936 Sjobring, 1988, Isolation and characterization of a 14-kDa albumin-binding fragment of streptococcal protein G, J. Immunol., 140, 1595, 10.4049/jimmunol.140.5.1595 Kraulisa, 1996, The serum albumin-binding domain of streptococcal protein G is a three-helical bundle: a heteronuclear NMR study, FEBS Lett., 378, 190, 10.1016/0014-5793(95)01452-7 Malm, 2014, Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension, Biotechnol. J., 9, 1215, 10.1002/biot.201400009 Löfblom, 2010, Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications, FEBS Lett., 584, 2670, 10.1016/j.febslet.2010.04.014 Makrides, 1996, Extended in vivo half-life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor, J. Pharmacol. Exp. Ther., 277 Nessler, 2020, Increased tumor penetration of single-domain antibody-drug conjugates improves in vivo efficacy in prostate cancer models, Cancer Res., 80, 1268, 10.1158/0008-5472.CAN-19-2295 Hammarberg, 1989, Dual affinity fusion approach and its use to express recombinant human insulin-like growth factor II, Proc. Natl. Acad. Sci. U. S. A., 86, 4367, 10.1073/pnas.86.12.4367 Guo, 2016, Fusion of an albumin-binding domain extends the half-life of immunotoxins, Int. J. Pharm., 511, 538, 10.1016/j.ijpharm.2016.07.046 Libon, 1999, The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein, Vaccine., 17, 406, 10.1016/S0264-410X(98)00198-4 Smith, 2016, Albumin-polymer-drug conjugates: long circulating, high payload drug delivery vehicles, ACS Macro Lett., 5, 1089, 10.1021/acsmacrolett.6b00544 Hartung, 1999, Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society, Clin. Cancer Res., 5, 753 Vis, 2002, A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy, Cancer Chemother. Pharmacol., 49, 342, 10.1007/s00280-001-0417-z Bolling, 2006, Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma, Investig. New Drugs, 24, 521, 10.1007/s10637-006-8221-6 Desai, 2006, Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel, Clin. Cancer Res., 12, 1317, 10.1158/1078-0432.CCR-05-1634 Elsadek, 2012, Impact of albumin on drug delivery - new applications on the horizon, J. Control. Release, 157, 4, 10.1016/j.jconrel.2011.09.069 Van de Sande, 2020, Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review, Drug Deliv., 27, 40, 10.1080/10717544.2019.1704945 Lin, 2016, Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for Antiglioma therapy, ACS Nano, 10, 9999, 10.1021/acsnano.6b04268 Jiang, 2017, Influencing selectivity to Cancer cells with mixed nanoparticles prepared from albumin-polymer conjugates and block copolymers, Bioconjug. Chem., 28, 979, 10.1021/acs.bioconjchem.6b00698 Li, 2009, Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis, J. Pharm. Pharmacol., 61, 1155, 10.1211/jpp.61.09.0004 Sun, 2019, Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy, Int. J. Nanomedicine, 14, 135, 10.2147/IJN.S181296 Fadaeian, 2015, Targeted delivery of 5-fluorouracil with monoclonal antibody modified bovine serum albumin nanoparticles, Iran. J. Pharm. Res., 14, 395 Xiong, 2018, Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor 2-positive gastric cancer, Oncol. Rep., 39, 1396 Saleh, 2019, Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells, Int. J. Biol. Macromol., 130, 109, 10.1016/j.ijbiomac.2019.02.129 Kenet, 2017, Recombinant fusion protein linking coagulation Factor IX with albumin (RIX-FP) in previously treated children < 12 years of age with Hemophilia B: long-term efficacy and safety from an ongoing phase 3b extension clinical trial, Blood., 130, 2370 Shao, 2008, Enediyne anticancer antibiotic Lidamycin: chemistry, biology and pharmacology, Anti Cancer Agents Med. Chem., 8, 123, 10.2174/187152008783497055 Li, 2018, The recombinant and reconstituted novel albumin-Lidamycin conjugate shows lasting tumor imaging and intensively enhanced therapeutic efficacy, Bioconjug. Chem., 29, 3104, 10.1021/acs.bioconjchem.8b00456 Lei, 2012, Expression, purification and characterization of recombinant human interleukin-2-serum albumin (rhIL-2-HSA) fusion protein in Pichia pastoris, Protein Expr. Purif., 84, 154, 10.1016/j.pep.2012.05.003 Melder, 2005, Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice, Cancer Immunol. Immunother., 54, 535, 10.1007/s00262-004-0624-7 Sung, 2003, An IFN-β-albumin fusion protein that displays improved pharmacokinetic and pharmacodynamic properties in nonhuman primates, J. Interf. Cytokine Res., 23, 25, 10.1089/10799900360520423 Nguyen, 2020, Bacterial overexpression and purification of soluble recombinant human serum albumin using maltose-binding protein and protein disulphide isomerase, Protein Expr. Purif., 167, 105530, 10.1016/j.pep.2019.105530 Gelse, 2003, Collagens - structure, function, and biosynthesis, Adv. Drug Deliv. Rev., 55, 1531, 10.1016/j.addr.2003.08.002 Ricard-Blum, 2011, The collagen family, Cold Spring Harb. Perspect. Biol., 3, 1, 10.1101/cshperspect.a004978 Ruszczak, 2003, Collagen as a carrier for on-site delivery of antibacterial drugs, Adv. Drug Deliv. Rev., 55, 1679, 10.1016/j.addr.2003.08.007 Ramachandran, 1955, Structure of collagen, Nature., 176, 593, 10.1038/176593a0 Heidemann, 1982, Synthesis and investigation of collagen model peptides, Adv. Polym. Sci., 143, 10.1007/3-540-11048-8_3 Chak, 2013 Mandal, 1934, Collagen as biomaterial for medical application-drug delivery and scaffolds for tissue regeneration: a review, Biol. Eng., 2, 63, 10.13031/2013.32719 M. Violeta GHICA, M. Georgiana ALBU, L. Popa, M. Leca, L. Brăzdaru, C. Cotruţ, V. Trandafir, 2009 Luo, 2013, Collagen-like peptides and peptide-polymer conjugates in the design of assembled materials, Eur. Polym. J., 49, 2998, 10.1016/j.eurpolymj.2013.05.013 Luo, 2017, Collagen-Like Peptide Bioconjugates, Bioconjug. Chem., 28, 816, 10.1021/acs.bioconjchem.6b00673 Persikov, 2000, Amino acid propensities for the collagen triple-helix, Biochemistry., 39, 14960, 10.1021/bi001560d Yu, 2011, Collagen mimetic peptides: Progress towards functional applications, Soft Matter, 7, 7927, 10.1039/c1sm05329a Chung, 1974, Isolation and characterization of the cyanogen bromide peptides from the α1(III)chain of human collagen, Biochemistry., 13, 3459, 10.1021/bi00714a006 Barth, 2003, The role of cystine knots in collagen folding and stability, part II. Conformational properties of (Pro-Hyp-Gly)n model trimers with N- and C-terminal collagen type III cystine knots, Chem. - A Eur. J., 9, 3703, 10.1002/chem.200304918 BÄCHINGER, 1980, Folding mechanism of the triple Helix in type-III collagen and type-III pN–collagen: role of disulfide bridges and peptide bond isomerization, Eur. J. Biochem., 106, 619, 10.1111/j.1432-1033.1980.tb04610.x Kwak, 2002, TREN (tris(2-aminoethyl)amine): An effective scaffold for the assembly of triple helical collagen mimetic structures, J. Am. Chem. Soc., 124, 14085, 10.1021/ja0209621 Feng, 1996, Acetyl-terminated and template-assembled collagen-based polypeptides composed of Gly-Pro-Hyp sequences. 2. Synthesis and conformational analysis by circular dichroism, ultraviolet absorbance, and optical rotation, J. Am. Chem. Soc., 118, 10351, 10.1021/ja961260c Koide, 2002, Metal-assisted stabilization and probing of collagenous triple helices, J. Am. Chem. Soc., 124, 9388, 10.1021/ja026182+ Parmar, 2015, Metal stabilization of collagen and de novo designed mimetic peptides, Biochemistry., 54, 4987, 10.1021/acs.biochem.5b00502 Yu, 1996, Self-assembling amphiphiles for construction of protein molecular architecture, J. Am. Chem. Soc., 118, 12515, 10.1021/ja9627656 Gore, 2001, Self-assembly of model collagen peptide amphiphiles, Langmuir., 17, 5352, 10.1021/la010223i Yu, 1998, Minimal lipidation stabilizes protein-like molecular architecture, J. Am. Chem. Soc., 120, 9979, 10.1021/ja981654z Inouy, 1976, Effects of the stereo-configuration of the hydroxyl group in 4-hydroxyproline on the triple-helical structures formed by homogeneous peptides resembling collagen, BBA - Protein Struct., 420, 133, 10.1016/0005-2795(76)90352-4 Eberhardt, 1996, Inductive effects on the energetics of prolyl peptide bond isomerization: implications for collagen folding and stability, J. Am. Chem. Soc., 118, 12261, 10.1021/ja9623119 Steven, 1998, Code for collagen's stability deciphered, Nature, 392, 666, 10.1038/33573 Holmgren, 1999, A hyperstable collagen mimic, Chem. Biol., 6, 63, 10.1016/S1074-5521(99)80003-9 Hsu, 2012, Promoting self-assembly of collagen-related peptides into various higher-order structures by metal–Histidine coordination, Langmuir., 28, 3194, 10.1021/la204351w Pires, 2009, Self-assembly of collagen peptides into microflorettes via metal coordination, J. Am. Chem. Soc., 131, 2706, 10.1021/ja8088845 Zheng, 2018, How electrostatic networks modulate specificity and stability of collagen, Proc. Natl. Acad. Sci. U. S. A., 115, 6207, 10.1073/pnas.1802171115 Wang, 2005, Facile modification of collagen directed by collagen mimetic peptides, J. Am. Chem. Soc., 127, 4130, 10.1021/ja0431915 Li, 2013, Targeting and mimicking collagens via triple helical peptide assembly, Curr. Opin. Chem. Biol., 17, 968, 10.1016/j.cbpa.2013.10.018 Bennink, 2017, High serum stability of collagen hybridizing peptides and their Fluorophore conjugates, Mol. Pharm., 14, 1906, 10.1021/acs.molpharmaceut.7b00009 Converse, 2018, Detection and characterization of molecular-level collagen damage in overstretched cerebral arteries, Acta Biomater., 67, 307, 10.1016/j.actbio.2017.11.052 San, 2017, Self-assembled water-soluble nanofibers displaying collagen hybridizing peptides, J. Am. Chem. Soc., 139, 16640, 10.1021/jacs.7b07900 Hwang, 2017, Molecular assessment of collagen denaturation in decellularized tissues using a collagen hybridizing peptide, Acta Biomater., 53, 268, 10.1016/j.actbio.2017.01.079 Wang, 2008, Spatio-temporal modification of collagen scaffolds mediated by triple helical propensity, Biomacromolecules., 9, 1755, 10.1021/bm701378k Li, 2013, Direct detection of collagenous proteins by fluorescently labeled collagen mimetic peptides, Bioconjug. Chem., 24, 9, 10.1021/bc3005842 Li, 2012, Targeting collagen strands by photo-triggered triple-helix hybridization, Proc. Natl. Acad. Sci. U. S. A., 109, 14767, 10.1073/pnas.1209721109 Bennink, 2018, Visualizing collagen proteolysis by peptide hybridization: from 3D cell culture to in vivo imaging, Biomaterials., 183, 67, 10.1016/j.biomaterials.2018.08.039 Wang, 2008, Immobilization of growth factors on collagen scaffolds mediated by polyanionic collagen mimetic peptides and its effect on endothelial cell morphogenesis, Biomacromolecules., 9, 2929, 10.1021/bm800727z Mo, 2006, Nanoparticle-assisted visualization of binding interactions between collagen mimetic peptide and collagen fibers, Angew. Chemie., 118, 2325, 10.1002/ange.200504529 Santos, 2014, Conducting polymer nanoparticles decorated with collagen mimetic peptides for collagen targeting, Chem. Commun., 50, 15045, 10.1039/C4CC06056C Urello, 2014, A CMP-based method for tunable, cell-mediated gene delivery from collagen scaffolds, J. Mater. Chem. B, 2, 8174, 10.1039/C4TB01435A Urello, 2016, Integration of growth factor gene delivery with collagen-triggered wound repair cascades using collagen-mimetic peptides, Bioeng. Transl. Med., 1, 207, 10.1002/btm2.10037 Mansurov, 2020, Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours, Nat. Biomed. Eng., 4, 531, 10.1038/s41551-020-0549-2 Kotch, 2006, Self-assembly of synthetic collagen triple helices, Proc. Natl. Acad. Sci. U. S. A., 103, 3028, 10.1073/pnas.0508783103 Koide, 2005, Self-complementary peptides for the formation of collagen-like triple helical supramolecules, Bioorganic Med. Chem. Lett., 15, 5230, 10.1016/j.bmcl.2005.08.041 Yamazaki, 2008, Artificial collagen gels via self-assembly of de novo designed peptides, Biopolymers., 90, 816, 10.1002/bip.21100 Yamazaki, 2010, A collagen-mimetic triple helical supramolecule that evokes integrin-dependent cell responses, Biomaterials., 31, 1925, 10.1016/j.biomaterials.2009.10.014 Ichise, 2019, Development of a collagen-like peptide polymer via end-to-end disulfide cross-linking and its application as a biomaterial, Acta Biomater., 94, 361, 10.1016/j.actbio.2019.06.010 Cejas, 2007, Collagen-related peptides: self-assembly of short, single strands into a functional biomaterial of micrometer scale, J. Am. Chem. Soc., 129, 2202, 10.1021/ja066986f Cejas, 2008, Thrombogenic collagen-mimetic peptides: self-assembly of triple helix-based fibrils driven by hydrophobic interactions, Proc. Natl. Acad. Sci., 105, 8513, 10.1073/pnas.0800291105 Rao, 1994, Promotion of human platelet adhesion and aggregation by a synthetic, triple-helical “mini-collagen”, J. Biol. Chem., 269, 13899, 10.1016/S0021-9258(17)36732-7 Kar, 2009, Aromatic interactions promote self-association of collagen triple-helical peptides to higher-order structures, Biochemistry., 48, 7959, 10.1021/bi900496m Chen, 2011, Self-assembly of short collagen-related peptides into fibrils via cation-π interactions, Biochemistry., 50, 2381, 10.1021/bi1018573 Yu, 1997, Construction of biologically active protein molecular architecture using self-assembling peptide-amphiphiles, Methods Enzymol., 289, 571, 10.1016/S0076-6879(97)89065-9 Yu, 1999, Structure and dynamics of peptide-amphiphiles incorporating triple- helical proteinlike molecular architecture, Biochemistry., 38, 1659, 10.1021/bi982315l Luo, 2011, Self-assembly of collagen-mimetic peptide amphiphiles into biofunctional nanofiber, ACS Nano, 5, 7739, 10.1021/nn202822f Rele, 2007, D-periodic collagen-mimetic microfibers, J. Am. Chem. Soc., 129, 14780, 10.1021/ja0758990 O'Leary, 2011, Multi-hierarchical self-assembly of a collagen mimetic peptide from triple helix to nanofibre and hydrogel, Nat. Chem., 3, 821, 10.1038/nchem.1123 Tanrikulu, 2016, Peptide tessellation yields micrometre-scale collagen triple helices, Nat. Chem., 8, 1008, 10.1038/nchem.2556 Lee, 2008, Investigation of pH-dependent collagen triple-Helix formation, Angew. Chemie Int. Ed., 47, 8429, 10.1002/anie.200802224 Pires, 2011, Metal-mediated tandem Coassembly of collagen peptides into banded microstructures, J. Am. Chem. Soc., 133, 14469, 10.1021/ja2042645 Pires, 2012, Controlling the morphology of metal-promoted higher ordered assemblies of collagen peptides with varied Core lengths, Langmuir., 28, 1993, 10.1021/la203848r Pires, 2009, A metal-collagen peptide framework for three-dimensional cell culture, Angew. Chemie Int. Ed., 48, 7813, 10.1002/anie.200902375 Pires, 2011, Selective decoration and release of his-tagged proteins from metal-assembled collagen peptide Microflorettes, Biomacromolecules., 12, 2429, 10.1021/bm2004934 Nepal, 2016, Accessing three-dimensional crystals with incorporated guests through metal-directed coiled-coil peptide assembly, J. Am. Chem. Soc., 138, 11051, 10.1021/jacs.6b06708 Strauss, 2017, Advances in the design and higher-order assembly of collagen mimetic peptides for regenerative medicine, Curr. Opin. Biotechnol., 46, 34, 10.1016/j.copbio.2016.10.013 Luo, 2017, Thermoresponsive elastin-b-collagen-like peptide bioconjugate nanovesicles for targeted drug delivery to collagen-containing matrices, Biomacromolecules., 18, 2539, 10.1021/acs.biomac.7b00686 Luo, 2015, Noncovalent modulation of the inverse temperature transition and self-assembly of elastin-b-collagen-like peptide bioconjugates, J. Am. Chem. Soc., 137, 15362, 10.1021/jacs.5b09941 Qin, 2019, Self-Assembly of Stable Nanoscale Platelets from Designed Elastin-like Peptide-Collagen-like Peptide Bioconjugates, Biomacromolecules, 10.1021/acs.biomac.8b01681 Prhashanna, 2019, Effect of peptide sequence on the LCST-like transition of elastin-like peptides and elastin-like peptide-collagen-like peptide conjugates: simulations and experiments, Biomacromolecules., 20, 1178, 10.1021/acs.biomac.8b01503 Luo, 2015, Noncovalent modulation of the inverse temperature transition and self-assembly of elastin-b-collagen-like peptide bioconjugates, J. Am. Chem. Soc., 137, 15362, 10.1021/jacs.5b09941 Luo, 2015, Thermoresponsive self-assembly of nanostructures from a collagen-like peptide-containing Diblock copolymer, Macromol. Biosci., 15, 111, 10.1002/mabi.201400358 Luo, 2017, Thermoresponsive elastin-b-collagen-like peptide bioconjugate Nanovesicles for targeted drug delivery to collagen-containing matrices, Biomacromolecules., 18, 2539, 10.1021/acs.biomac.7b00686 Bello, 2020, Engineering and functionalization of gelatin biomaterials: from cell culture to medical applications, Tissue Eng. - Part B Rev., 26, 164, 10.1089/ten.teb.2019.0256 Djagny, 2001, Gelatin: a valuable protein for food and pharmaceutical industries: review, Crit. Rev. Food Sci. Nutr., 41, 481, 10.1080/20014091091904 Flory, 1960, Helix ⇆ Coil Transitions in Dilute Aqueous Collagen Solutions, J. Am. Chem. Soc., 82, 4518, 10.1021/ja01502a018 Elzoghby, 2013, Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research, J. Control. Release, 172, 1075, 10.1016/j.jconrel.2013.09.019 Gorgieva, 2011, Collagen- vs. Gelatine-Based Biomaterials and Their Biocompatibility: Review and Perspectives Sahoo, 2015, Recent advancement of gelatin nanoparticles in drug and vaccine delivery, Int. J. Biol. Macromol., 81, 317, 10.1016/j.ijbiomac.2015.08.006 Su, 2015, Recent advances in the use of gelatin in biomedical research, Biotechnol. Lett., 37, 2139, 10.1007/s10529-015-1907-0 Olsen, 2003, Recombinant collagen and gelatin for drug delivery, Adv. Drug Deliv. Rev., 55, 1547, 10.1016/j.addr.2003.08.008 Kommareddy, 2007 Liang, 2004, Crosslinking structures of gelatin hydrogels crosslinked with genipin or a water-soluble carbodiimide, J. Appl. Polym. Sci., 91, 4017, 10.1002/app.13563 Harrington, 1970, Collagen Structure in Solution. I. Kinetics of Helix Regeneration in Single-Chain Gelatins, Biochemistry, 9, 3714, 10.1021/bi00821a010 Bello, 1956, Mechanism of gelation of gelatin. Influence of certain electrolytes on the melting points of gels of gelatin and chemically modified gelatins, J. Phys. Chem., 60, 1299, 10.1021/j150543a035 Djabourov, 1988, Gelation of aqueous gelatin solutions. I. Structural investigation, J. Phys., 49, 319, 10.1051/jphys:01988004902031900 Lee, 2011, Gelatin nanoparticle preparation by nanoprecipitation, J. Biomater. Sci. Polym. Ed., 22, 753, 10.1163/092050610X492093 Li, 2011, Effects of mass ratio, pH, temperature, and reaction time on fabrication of partially purified pomegranate ellagitannin-gelatin nanoparticles, J. Agric. Food Chem., 59, 4225, 10.1021/jf200024d FARRUGIA, 1999, Gelatin behaviour in dilute aqueous solution: designing a Nanoparticulate formulation, J. Pharm. Pharmacol., 51, 643, 10.1211/0022357991772925 Saxena, 2005, Effect of molecular weight heterogeneity on drug encapsulation efficiency of gelatin nano-particles, Colloids Surfaces B Biointerfaces., 45, 42, 10.1016/j.colsurfb.2005.07.005 Bajpai, 2006, Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate, J. Mater. Sci. Mater. Med., 17, 345, 10.1007/s10856-006-8235-9 Amjadi, 2019, A novel smart PEGylated gelatin nanoparticle for co-delivery of doxorubicin and betanin: a strategy for enhancing the therapeutic efficacy of chemotherapy, Mater. Sci. Eng. C., 97, 833, 10.1016/j.msec.2018.12.104 Wang, 2013, Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo, J. Control. Release, 166, 172, 10.1016/j.jconrel.2012.12.015 Narayanan, 2013, Poly-(ethylene glycol) modified gelatin nanoparticles for sustained delivery of the anti-inflammatory drug ibuprofen-sodium: An in vitro and in vivo analysis, Nanomed. Nanotechnol. Biol. Med., 9, 818, 10.1016/j.nano.2013.02.001 Carvalho, 2019, Functionalized photosensitive gelatin nanoparticles for drug delivery application, J. Biomater. Sci. Polym. Ed., 30, 508, 10.1080/09205063.2019.1580664 Kirar, 2018, Development of gelatin nanoparticle-based biodegradable Phototheranostic agents: advanced system to treat infectious diseases, ACS Biomater. Sci. Eng., 4, 473, 10.1021/acsbiomaterials.7b00751 Yarchoan, 1989, In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine, Science (80-. ), 245, 412, 10.1126/science.2502840 Zhang, 2020, Stiffness of cationized gelatin nanoparticles is a key factor determining RNAi efficiency in myeloid leukemia cells, Chem. Commun., 56, 1255, 10.1039/C9CC09068A Solorio, 2012, Engineered cartilage via self-assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-β1, J. Control. Release, 158, 224, 10.1016/j.jconrel.2011.11.003 Patel, 2008, In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds, Pharm. Res., 25, 2370, 10.1007/s11095-008-9685-1 Patel, 2008, Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2, Acta Biomater., 4, 1126, 10.1016/j.actbio.2008.04.002 Huang, 2009, Fabrication and characterization of a novel microparticle with gyrus-patterned surface and growth factor delivery for cartilage tissue engineering, Mater. Sci. Eng. C., 29, 1351, 10.1016/j.msec.2008.10.036 Nguyen, 2016, MMP-mediated mesenchymal morphogenesis of pluripotent stem cell aggregates stimulated by gelatin methacrylate microparticle incorporation, Biomaterials., 76, 66, 10.1016/j.biomaterials.2015.10.043 Gómez-Estaca, 2017, Improving antioxidant and antimicrobial properties of curcumin by means of encapsulation in gelatin through electrohydrodynamic atomization, Food Hydrocoll., 70, 313, 10.1016/j.foodhyd.2017.04.019 Madan, 2013, Sterically stabilized gelatin microassemblies of noscapine enhance cytotoxicity, apoptosis and drug delivery in lung cancer cells, Colloids Surfaces B Biointerfaces., 107, 235, 10.1016/j.colsurfb.2013.02.010 Kim, 2018, Monodisperse microshell structured gelatin microparticles for temporary chemoembolization, Biomacromolecules., 19, 386, 10.1021/acs.biomac.7b01479 Li, 2016, Electrospun gelatin nanofibers loaded with vitamins a and e as antibacterial wound dressing materials, RSC Adv., 6, 50267, 10.1039/C6RA05092A Del Gaudio, 2013, Induction of angiogenesis using VEGF releasing genipin-crosslinked electrospun gelatin mats, Biomaterials., 34, 7754, 10.1016/j.biomaterials.2013.06.040 Jaipan, 2017, Gelatin-based hydrogels for biomedical applications, MRS Commun., 7, 416, 10.1557/mrc.2017.92 Lin, 2014, Cartilage tissue engineering application of injectable gelatin hydrogel with in situ visible-light-activated gelation capability in both air and aqueous solution, Tissue Eng. - Part A., 20, 2402, 10.1089/ten.tea.2013.0642 Mazaki, 2014, A novel, visible light-induced, rapidly cross-linkable gelatin scaffold for osteochondral tissue engineering, Sci. Rep., 4, 1, 10.1038/srep04457 Oun, 2014, A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol, J. Inorg. Biochem., 134, 100, 10.1016/j.jinorgbio.2014.02.004 Jiang, 2018, Bioprintable alginate/gelatin hydrogel 3D in vitro model systems induce cell spheroid formation, J. Vis. Exp., 2018 Jiang, 2020, Engineering bioprintable alginate/gelatin composite hydrogels with tunable mechanical and cell adhesive properties to modulate tumor spheroid growth kinetics, Biofabrication, 12 Jiang, 2017, Directing the Self-Assembly of Tumour Spheroids by Bioprinting Cellular Heterogeneous Models within Alginate/Gelatin Hydrogels, Sci. Rep., 7 Foox, 2014, In vitro microbial inhibition, bonding strength, and cellular response to novel gelatin-alginate antibiotic-releasing soft tissue adhesives, Polym. Adv. Technol., 25, 516, 10.1002/pat.3278 Cohen, 2014, Novel gelatin/alginate soft tissue adhesives loaded with drugs for pain management: structure and properties, J. Biomater. Sci. Polym. Ed., 25, 224, 10.1080/09205063.2013.849904 Mithieux, 2005, Elastin, 437 Almine, 2010, Elastin-based materials, Chem. Soc. Rev., 39, 3371, 10.1039/b919452p MacEwan, 2014, Applications of elastin-like polypeptides in drug delivery, J. Control. Release, 190, 314, 10.1016/j.jconrel.2014.06.028 MacEwan, 2010, Elastin-like polypeptides: biomedical applications of tunable biopolymers, Pept. Sci., 94, 60, 10.1002/bip.21327 Li, 2014, Molecular description of the LCST behavior of an elastin-like polypeptide, Biomacromolecules., 15, 3522, 10.1021/bm500658w Ougizawa, 1985, UCST and LCST behavior in polymer blends, Macromolecules., 18, 2089, 10.1021/ma00152a052 McDaniel, 2013, A unified model for de novo design of elastin-like polypeptides with tunable inverse transition temperatures, Biomacromolecules., 14, 2866, 10.1021/bm4007166 Urry, 1986, Temperature dependence of length of elastin and its polypentapeptide, Biochem. Biophys. Res. Commun., 141, 749, 10.1016/S0006-291X(86)80236-4 Trabbic-Carlson, 2004, Effect of protein fusion on the transition temperature of an environmentally responsive elastin-like polypeptide: a role for surface hydrophobicity?, Protein Eng. Des. Sel., 17, 57, 10.1093/protein/gzh006 Christensen, 2013, Predicting transition temperatures of elastin-like polypeptide fusion proteins, Biomacromolecules., 14, 1514, 10.1021/bm400167h Meyer, 1999, Purification of recombinant proteins by fusion with thermally-responsive polypeptides, Nat. Biotechnol., 17, 1112, 10.1038/15100 Trabbic-Carlson, 2004, Expression and purification of recombinant proteins from Escherichia coli: comparison of an elastin-like polypeptide fusion with an oligohistidine fusion, Protein Sci., 13, 3274, 10.1110/ps.04931604 Banki, 2005, Simple bioseparations using self-cleaving elastin-like polypeptide tags, Nat. Methods, 2, 659, 10.1038/nmeth787 Shen, 2010, Expression and purification of moricin CM4 and human β-defensins 4 in Escherichia coli using a new technology, Microbiol. Res., 165, 713, 10.1016/j.micres.2010.01.002 Bruno, 2013, Basics and recent advances in peptide and protein drug delivery, Ther. Deliv., 4, 1443, 10.4155/tde.13.104 Takakura, 1996, Macromolecular carrier Systems for Targeted Drug Delivery: pharmacokinetic considerations on biodistribution, Pharm. Res., 13, 820, 10.1023/A:1016084508097 Kalepu, 2015, Insoluble drug delivery strategies: review of recent advances and business prospects, Acta Pharm. Sin. B, 5, 442, 10.1016/j.apsb.2015.07.003 Tiwari, 2012, Drug delivery systems: An updated review, Int. J. Pharm. Investig., 2, 2, 10.4103/2230-973X.96920 Conley, 2009, Optimization of elastin-like polypeptide fusions for expression and purification of recombinant proteins in plants, Biotechnol. Bioeng., 103, 562, 10.1002/bit.22278 Conrad, 2011, ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock, Plant Biotechnol. J., 9, 22, 10.1111/j.1467-7652.2010.00523.x Phan, 2014, Influence of elastin-like polypeptide and hydrophobin on recombinant hemagglutinin accumulations in transgenic tobacco plants, PLoS One, 9, e99347, 10.1371/journal.pone.0099347 Holloway, 2018, Drug delivery in stealth mode, Sci. Transl. Med., 10, 10.1126/scitranslmed.aaw0523 Salmaso, 2013, Stealth properties to improve therapeutic efficacy of drug nanocarriers, J. Drug Deliv., 10.1155/2013/374252 Banskota, 2019, Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery, Biomaterials., 192, 475, 10.1016/j.biomaterials.2018.11.012 Lee, 2000, Thermo-reversible self-assembly of nanoparticles derived from elastin-mimetic polypeptides, Adv. Mater., 12, 1105, 10.1002/1521-4095(200008)12:15<1105::AID-ADMA1105>3.0.CO;2-1 Wright, 2002, Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences, Adv. Drug Deliv. Rev., 54, 1057, 10.1016/S0169-409X(02)00059-5 Wright, 2002, Thermoplastic elastomer hydrogels via self-assembly of an elastin-mimetic Triblock polypeptide, Adv. Funct. Mater., 12, 149, 10.1002/1616-3028(20020201)12:2<149::AID-ADFM149>3.0.CO;2-N Dreher, 2008, Temperature triggered self-assembly of polypeptides into multivalent spherical micelles, J. Am. Chem. Soc., 130, 687, 10.1021/ja0764862 Janib, 2014, A quantitative recipe for engineering protein polymer nanoparticles, Polym. Chem., 5, 1614, 10.1039/C3PY00537B Hassouneh, 2015, Elastin-like polypeptide Diblock copolymers self-assemble into weak micelles, Macromolecules., 48, 4183, 10.1021/acs.macromol.5b00431 Simnick, 2010, Morphing low-affinity ligands into high-avidity nanoparticles by thermally triggered self-assembly of a genetically encoded polymer, ACS Nano, 4, 2217, 10.1021/nn901732h Macewan, 2012, Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake, Nano Lett., 12, 3322, 10.1021/nl301529p Wender, 2000, The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters, Proc. Natl. Acad. Sci. U. S. A., 97, 13003, 10.1073/pnas.97.24.13003 Hassouneh, 2012, Unexpected multivalent display of proteins by temperature triggered self-assembly of elastin-like polypeptide block copolymers, Biomacromolecules., 13, 1598, 10.1021/bm300321n Sun, 2011, Design and cellular internalization of genetically engineered polypeptide nanoparticles displaying adenovirus knob domain, J. Control. Release, 155, 218, 10.1016/j.jconrel.2011.06.010 Hsueh, 2015, Tear-mediated delivery of nanoparticles through transcytosis of the lacrimal gland, J. Control. Release, 208, 2, 10.1016/j.jconrel.2014.12.017 Callahan, 2012, Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution, Nano Lett., 12, 2165, 10.1021/nl300630c Shah, 2013, A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome, J. Control. Release, 171, 269, 10.1016/j.jconrel.2013.07.016 Shi, 2013, Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo, J. Control. Release, 171, 330, 10.1016/j.jconrel.2013.05.013 McDaniel, 2014, Noncanonical self-assembly of highly asymmetric genetically encoded polypeptide amphiphiles into cylindrical micelles, Nano Lett., 14, 6590, 10.1021/nl503221p Aluri, 2014, A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibody, ACS Nano, 8, 2064, 10.1021/nn403973g Pastuszka, 2014, An amphipathic alpha-helical peptide from apolipoprotein A1 stabilizes protein polymer vesicles, J. Control. Release, 191, 15, 10.1016/j.jconrel.2014.07.003 McDaniel, 2013, Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugation, Angew. Chem. Int. Ed. Engl., 52, 1683, 10.1002/anie.201200899 Bhattacharyya, 2015, A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models, Nat. Commun., 6, 7939, 10.1038/ncomms8939 Bhattacharyya, 2017, Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth, Nanoscale., 9, 12709, 10.1039/C7NR01973D Bhattacharyya, 2017, Encapsulating a hydrophilic chemotherapeutic into rod-like nanoparticles of a genetically encoded asymmetric Triblock polypeptide improves its efficacy, Adv. Funct. Mater., 27, 1605421, 10.1002/adfm.201605421 Costa, 2019, Active targeting of cancer cells by Nanobody decorated polypeptide micelle with bio-orthogonally conjugated drug, Nano Lett., 19, 247, 10.1021/acs.nanolett.8b03837 Luginbuhl, 2017, Recombinant synthesis of hybrid lipid-peptide polymer fusions that self-assemble and encapsulate hydrophobic drugs, Angew. Chem. Int. Ed. Engl., 56, 13979, 10.1002/anie.201704625 Huang, 2015, Silk-elastin-like protein biomaterials for the controlled delivery of therapeutics, Expert Opin. Drug Deliv., 12, 779, 10.1517/17425247.2015.989830 Xia, 2011, Tunable self-assembly of genetically engineered silk--elastin-like protein polymers, Biomacromolecules., 12, 3844, 10.1021/bm201165h Xia, 2014, Hydrophobic drug-triggered self-assembly of nanoparticles from silk-elastin-like protein polymers for drug delivery, Biomacromolecules., 15, 908, 10.1021/bm4017594 Liu, 2010, Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model, J. Control. Release, 144, 2, 10.1016/j.jconrel.2010.01.032 Liu, 2012, Brachytherapy Using Injectable Seeds That Are Self-Assembled from Genetically Encoded Polypeptides <em>In Situ</em&gt, Cancer Res., 72, 10.1158/0008-5472.CAN-12-2127 Schaal, 2016, Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy, J. Control. Release, 228, 58, 10.1016/j.jconrel.2016.02.040 Wang, 2019, One-month zero-order sustained release and tumor eradication after a single subcutaneous injection of interferon alpha fused with a body-temperature-responsive polypeptide, Biomater. Sci., 7, 104, 10.1039/C8BM01096J Amiram, 2013, Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control, Proc. Natl. Acad. Sci. U. S. A., 110, 2792, 10.1073/pnas.1214518110 Luginbuhl, 2017, One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer, Nat. Biomed. Eng., 1, 78, 10.1038/s41551-017-0078 Gilroy, 2018, Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action, J. Control. Release, 277, 154, 10.1016/j.jconrel.2018.03.015 Wang, 2015, A thermo-responsive protein treatment for dry eyes, J. Control. Release, 199, 156, 10.1016/j.jconrel.2014.11.016 Adams, 2009, Sustained release of antibiotics from injectable and thermally responsive polypeptide depots, J Biomed Mater Res B Appl Biomater, 90, 67 Shamji, 2007, Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic, Arthritis Rheum., 56, 3650, 10.1002/art.22952 PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge Nasdaq:PHAS, (n.d.). https://www.globenewswire.com/news-release/2019/04/09/1799631/0/en/PhaseBio-Announces-Global-License-of-PB1023-for-the-Treatment-of-Sarcopenia-Related-Diseases-to-ImmunoForge.html (accessed August 13, 2020). GlobeNewswire, PhaseBio Announces Case Study Highlighting PB1046 Hemodynamic Data Presented at the 14th Pulmonary Vascular Research Institute World Congress, (2020). https://investors.phasebio.com/news-releases/news-release-details/phasebio-announces-case-study-highlighting-pb1046-hemodynamic (accessed August 13, 2020). Qin, 2012, Mechanism of resilin elasticity, Nat. Commun., 3, 10.1038/ncomms2004 Li, 2013, Resilin-like polypeptide hydrogels engineered for versatile biological functions, Soft Matter, 9, 665, 10.1039/C2SM26812D Li, 2013, Resilin-based materials for biomedical applications, ACS Macro Lett., 2, 635, 10.1021/mz4002194 Ardell, 2001, Tentative identification of a resilin gene in Drosophila melanogaster, Insect Biochem. Mol. Biol., 31, 965, 10.1016/S0965-1748(01)00044-3 Elvin, 2005, Synthesis and properties of crosslinked recombinant pro-resilin, Nature., 437, 999, 10.1038/nature04085 Lyons, 2009, Comparisons of recombinant Resilin-like proteins: repetitive domains are sufficient to confer Resilin-like properties, Biomacromolecules., 10, 3009, 10.1021/bm900601h Balu, 2015, Structural ensembles reveal intrinsic disorder for the multi-stimuli responsive bio-mimetic protein Rec1-resilin, Sci. Rep., 5, 1, 10.1038/srep10896 Lyons, 2012, Purification of recombinant protein by cold-coacervation of fusion constructs incorporating resilin-inspired polypeptides, Biotechnol. Bioeng., 109, 2947, 10.1002/bit.24565 Dutta, 2011, A genetically engineered protein responsive to multiple stimuli, Angew. Chemie - Int. Ed., 50, 4428, 10.1002/anie.201007920 Truong, 2010, A pH-responsive interface derived from resilin-mimetic protein Rec1-resilin, Biomaterials., 31, 4434, 10.1016/j.biomaterials.2010.02.019 Li, 2015, Temperature-triggered phase separation of a hydrophilic resilin-like polypeptide, Macromol. Rapid Commun., 36, 90, 10.1002/marc.201400521 Canning, 2017, pH-responsive schizophrenic Diblock copolymers prepared by polymerization-induced self-assembly, Macromolecules., 50, 6108, 10.1021/acs.macromol.7b01005 Maeda, 2004, Hydration changes during Thermosensitive Association of a Block Copolymer Consisting of LCST and UCST blocks, Macromol. Rapid Commun., 25, 1330, 10.1002/marc.200400062 Arotçaréna, 2002, Switching the inside and the outside of aggregates of water-soluble block copolymers with double Thermoresponsivity, J. Am. Chem. Soc., 124, 3787, 10.1021/ja012167d Weitzhandler, 2017, Micellar self-assembly of recombinant Resilin−/elastin-like block Copolypeptides, Biomacromolecules., 18, 2419, 10.1021/acs.biomac.7b00589 Charati, 2009, Hydrophilic elastomeric biomaterials based on resilin-like polypeptides, Soft Matter, 5, 3412, 10.1039/b910980c Li, 2011, Tunable mechanical stability and deformation response of a Resilin-based elastomer, Biomacromolecules., 12, 2302, 10.1021/bm200373p Renner, 2012, Characterization of Resilin-based materials for tissue engineering applications, Biomacromolecules., 13, 3678, 10.1021/bm301129b D'Andrea, 2005, Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide, Proc. Natl. Acad. Sci. U. S. A, 102, 10.1073/pnas.0505047102 Qin, 2009, Expression, cross-linking, and characterization of recombinant chitin binding Resilin, Biomacromolecules., 10, 3227, 10.1021/bm900735g Su, 2019, Redox-responsive Resilin-like hydrogels for tissue engineering and drug delivery applications, Macromol. Biosci., 19, 1, 10.1002/mabi.201900122 Li, 2013, Resilin-like polypeptide hydrogels engineered for versatile biological function, Soft Matter, 9, 665, 10.1039/C2SM26812D Bracalello, 2011, Design and production of a chimeric Resilin-, elastin-, and collagen-like engineered polypeptide, Biomacromolecules., 12, 2957, 10.1021/bm2005388 Megeed, 2002, Genetically engineered silk-elastinlike protein polymers for controlled drug delivery, Adv. Drug Deliv. Rev., 54, 1075, 10.1016/S0169-409X(02)00063-7 Maeda, 2001, The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting, Adv. Enzym. Regul., 41, 189, 10.1016/S0065-2571(00)00013-3 Parker, 2019, Design of Silk-Elastin-like Protein Nanoparticle Systems with Mucoadhesive properties, J. Funct. Biomater., 10, 49, 10.3390/jfb10040049 Cappello, 1998, In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs, J. Control. Release, 53, 105, 10.1016/S0168-3659(97)00243-5 Dinerman, 2002, Solute diffusion in genetically engineered silk–elastinlike protein polymer hydrogels, J. Control. Release, 82, 277, 10.1016/S0168-3659(02)00134-7 Megeed, 2002, Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel, Pharm. Res., 19, 954, 10.1023/A:1016406120288 Megeed, 2004, In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy, J. Control. Release, 94, 433, 10.1016/j.jconrel.2003.10.027 Hatefi, 2007, Adenoviral gene delivery to solid tumors by recombinant silk–Elastinlike protein polymers, Pharm. Res., 24, 773, 10.1007/s11095-006-9200-5 Price, 2012, Comparison of silk-elastinlike protein polymer hydrogel and poloxamer in matrix-mediated gene delivery, Int. J. Pharm., 427, 97, 10.1016/j.ijpharm.2011.09.037 Gustafson, 2010, Silk-elastin-like hydrogel improves the safety of adenovirus-mediated gene-directed enzyme−Prodrug therapy, Mol. Pharm., 7, 1050, 10.1021/mp100161u Jung, 2015, Direct observation of interactions of silk-Elastinlike protein polymer with adenoviruses and Elastase, Mol. Pharm., 12, 1673, 10.1021/acs.molpharmaceut.5b00075 Jensen, 2019, Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome, Biomaterials., 217, 119293, 10.1016/j.biomaterials.2019.119293 Jensen, 2017, Silk-elastinlike protein polymers enhance the efficacy of a therapeutic glycosaminoglycan for prophylactic treatment of radiation-induced proctitis, J. Control. Release, 263, 46, 10.1016/j.jconrel.2017.02.025 Schellenberger, 2009, A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner, Nat. Biotechnol., 27, 1186, 10.1038/nbt.1588 Ding, 2014, Multivalent antiviral XTEN–peptide conjugates with long in vivo half-life and enhanced solubility, Bioconjug. Chem., 25, 1351, 10.1021/bc500215m Podust, 2016, Extension of in vivo half-life of biologically active molecules by XTEN protein polymers, J. Control. Release, 240, 52, 10.1016/j.jconrel.2015.10.038 JL, 2012, Safety, pharmacokinetics, and pharmacodynamics of a single subcutaneous dose of VRS-859 in patients with type 2 diabetes, Am. Diabetes Assoc. Geething, 2010, Gcg-XTEN: An improved glucagon capable of preventing hypoglycemia without increasing baseline blood glucose, PLoS One, 5, 10.1371/journal.pone.0010175 Alters, 2012, GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's disease model, PLoS One, 7, 10.1371/journal.pone.0050630 Haeckel, 2014, XTEN-Annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation, J. Nucl. Med., 55, 508, 10.2967/jnumed.113.128108 Moore, 2016, A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency, J. Clin. Endocrinol. Metab, 101, 1091, 10.1210/jc.2015-3279 Leutjen, 2017, 017&#x2013;Safety and Efficacy of Somavaratan (VRS-317), a Long-Acting Growth Hormone, in Children with Growth Hormone Deficiency (GHD): 2.5-Year Results from the VISTA Trial, J. Pediatr. Nurs. Nurs. Care Child. Fam., 34, 107 van der Flier, 2015, Prolonged Half-Life and Improved Recovery of Recombinant Factor IX-XTEN Fusion Proteins in Hemophilia B Mouse Model Powell, 2012, Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients, Blood, 119, 3031, 10.1182/blood-2011-09-382846 Nolan, 2016, Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A, Haemophilia., 22, 72, 10.1111/hae.12766 Chhabra, 2020, BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice, Blood, 135, 1486 Haeckel, 2016, XTEN as biological alternative to PEGylation allows complete expression of a protease-Activatable Killin-based cytostatic, PLoS One, 11, 10.1371/journal.pone.0157193 Cattaruzza, 2020, HER2-XPAT and EGFR-XPAT: Pro-Drug T Cell Engagers (TCEs) Engineered to Address On-Target, Off-Tumor Toxicity With Potent Efficacy in vitro and in vivo and Large Safety Margins in NHP Schlapschy, 2013, PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins, Protein Eng. Des. Sel., 26, 489, 10.1093/protein/gzt023 Brandl, 2019, Influence of size and charge of unstructured polypeptides on pharmacokinetics and biodistribution of targeted fusion proteins, J. Control. Release, 307, 379, 10.1016/j.jconrel.2019.06.030 Strohl, 2015, Fusion proteins for half-life extension of biologics as a strategy to make biobetters, BioDrugs., 29, 215, 10.1007/s40259-015-0133-6 Harari, 2014, Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis, J. Biol. Chem., 289, 29014, 10.1074/jbc.M114.602474 Zvonova, 2017, PASylation technology improves recombinant interferon-β1b solubility, stability, and biological activity, Appl. Microbiol. Biotechnol., 101, 1975, 10.1007/s00253-016-7944-3 Morath, 2015, PASylation of murine Leptin leads to extended plasma half-life and enhanced in vivo efficacy, Mol. Pharm., 12, 1431, 10.1021/mp5007147 Bolze, 2016, Treatment of diet-induced lipodystrophic C57BL/6J mice with long-acting PASylated leptin normalises insulin sensitivity and hepatic steatosis by promoting lipid utilisation, Diabetologia., 59, 2005, 10.1007/s00125-016-4004-6 Hedayati, 2017, Molecular design, expression and evaluation of PASylated human recombinant erythropoietin with enhanced functional properties, Protein J., 36, 36, 10.1007/s10930-017-9699-9 Kuhn, 2016, PASylated Coversin, a C5-specific complement inhibitor with extended pharmacokinetics, shows enhanced anti-hemolytic activity in vitro, Bioconjug. Chem., 27, 2359, 10.1021/acs.bioconjchem.6b00369 Binder, 2017, PASylation®: a versatile technology to extend drug delivery, Curr. Opin. Colloid Interface Sci., 31, 10, 10.1016/j.cocis.2017.06.004 Falvo, 2016, Improved doxorubicin encapsulation and pharmacokinetics of ferritin–fusion protein Nanocarriers bearing Proline, serine, and alanine elements, Biomacromolecules., 17, 514, 10.1021/acs.biomac.5b01446 Fracasso, 2016, Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness, J. Control. Release, 239, 10, 10.1016/j.jconrel.2016.08.010 Morys, 2017, Influence of Defined Hydrophilic Blocks within Oligoaminoamide Copolymers: Compaction versus Shielding of pDNA Nanoparticles, Polym, 9 Bietz, 1970, Comparison of peptides from wheat gliadin and glutenin, Cereal Chem., 47 Arangoa, 2000, Bioadhesive potential of gliadin nanoparticulate systems, Eur. J. Pharm. Sci., 11, 333, 10.1016/S0928-0987(00)00121-4 Duclairoir, 2003, Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs, Int. J. Pharm., 253, 133, 10.1016/S0378-5173(02)00701-9 Arangoa, 2001, Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics, Pharm. Res., 18, 1521, 10.1023/A:1013018111829 Gulfam, 2012, Anticancer drug-loaded gliadin nanoparticles induce apoptosis in breast cancer cells, Langmuir., 28, 8216, 10.1021/la300691n Umamaheshwari, 2004, Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicilin in experimental gerbils model, AAPS PharmSciTech, 5, 10.1208/pt050232 Teng, 2009, Fractionation of soybean globulins using Ca2+ and Mg 2+: a comparative analysis, JAOCS, J. Am. Oil Chem. Soc., 86, 409, 10.1007/s11746-009-1367-6 Li, 2007, Effect of concentration, ionic strength and freeze-drying on the heat-induced aggregation of soy proteins, Food Chem., 104, 1410, 10.1016/j.foodchem.2007.02.003 Hong, 2005, Development of a bio-based composite material from soybean oil and keratin fibers, J. Appl. Polym. Sci., 95, 1524, 10.1002/app.21044 Teng, 2012, Nanoparticles synthesized from soy protein: preparation, characterization, and application for nutraceutical encapsulation, J. Agric. Food Chem., 60, 2712, 10.1021/jf205238x Ding, 2013, Soy protein/soy polysaccharide complex nanogels: folic acid loading, protection, and controlled delivery, Langmuir., 29, 8636, 10.1021/la401664y Chen, 2010, In vitro study of the release properties of soy-zein protein microspheres with a dynamic artificial digestive system, J. Agric. Food Chem., 58, 9861, 10.1021/jf101918w Chen, 2009, Elaboration and characterization of soy/zein protein microspheres for controlled nutraceutical delivery, Biomacromolecules., 10, 3327, 10.1021/bm900989y Hadzieva, 2017, Lactobacillus casei loaded soy protein-alginate microparticles prepared by spray-drying, Food Technol. Biotechnol., 55, 173, 10.17113/ftb.55.02.17.4991 Peles, 2013, Soy protein films for wound-healing applications: antibiotic release, bacterial inhibition and cellular response, J. Tissue Eng. Regen. Med., 7, 401, 10.1002/term.536 Song, 2009, Gelation modification of soy protein isolate by a naturally occurring cross-linking agent and its potential biomedical application, Ind. Eng. Chem. Res., 48, 7077, 10.1021/ie801372f Chen, 2008, Kinetics of the breakdown of cross-linked soy protein films for drug delivery, Biomaterials., 29, 3750, 10.1016/j.biomaterials.2008.05.025 Vaz, 2003, Soy matrix drug delivery systems obtained by melt-processing techniques, Biomacromolecules., 4, 1520, 10.1021/bm034050i Xu, 2009, Drug sorption onto and release from soy protein fibers, J. Mater. Sci. Mater. Med., 20, 2477, 10.1007/s10856-009-3821-2 Liu, 2005, Microspheres of corn protein, zein, for an ivermectin drug delivery system, Biomaterials., 26, 109, 10.1016/j.biomaterials.2004.02.013 Paliwal, 2014, Zein in controlled drug delivery and tissue engineering, J. Control. Release, 189, 108, 10.1016/j.jconrel.2014.06.036 P. Usa, P. Argos, K. Pedersenfl, M. David Marksl, B.A. Larkinsflll, A Structural Model for Maize Zein Proteins*, J. Biol. Chem. 257 (1982) 9984–9990. Matsushima, 1997, Three-dimensional structure of maize α-zein proteins studied by small-angle X-ray scattering, Biochim. Biophys. Acta - Protein Struct. Mol. Enzymol., 1339, 14, 10.1016/S0167-4838(96)00212-9 Wongsasulak, 2013, Fabrication, gastromucoadhesivity, swelling, and degradation of Zein-chitosan composite ultrafine fibers, J. Food Sci., 78, 926, 10.1111/1750-3841.12126 Liu, 2006, Pectin/zein beads for potential colon-specific drug delivery: synthesis and in vitro evaluation, Drug Deliv., 13, 417, 10.1080/10717540500394935 Gao, 2007, Study of a Pingyangmycin delivery system: Zein/Zein-SAIB in situ gels, Int. J. Pharm., 328, 57, 10.1016/j.ijpharm.2006.07.048 Cao, 2012, Doxorubicin-loaded zein in situ gel for interstitial chemotherapy, Chem. Pharm. Bull., 60, 1227, 10.1248/cpb.c12-00270 Matsuda, 2002, Novel preparation of Zein microspheres conjugated with PS-K available for Cancer immunotherapy, Chem. Pharm. Bull., 2091 Suzuki, 2002, Preparation of zein microspheres conjugated with antitumor drugs available for selective cancer chemotherapy and development of a simple colorimetric determination of drugs in microspheres, Chem. Pharm. Bull., 57, 364 Fu, 2009, Antibacterial activity of ciprofloxacin-loaded zein microsphere films, Mater. Sci. Eng. C., 29, 1161, 10.1016/j.msec.2008.09.031 Lau, 2012, Preparation and in vitro release of zein microparticles loaded with prednisolone for oral delivery, J. Microencapsul., 29, 706, 10.3109/02652048.2012.686527 Muthuselvi, 2006, Simple coacervates of zein to encapsulate Gitoxin, Colloids Surfaces B Biointerfaces., 51, 39, 10.1016/j.colsurfb.2006.05.012 Lai, 2011, Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting, Int. J. Pharm., 404, 317, 10.1016/j.ijpharm.2010.11.025 Dong, 2016, Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: preparation, in vitro evaluation, and cellular uptake, Colloids Surfaces B Biointerfaces., 140, 324, 10.1016/j.colsurfb.2015.12.048 Alhakamy, 2019, Encapsulation of lovastatin in zein nanoparticles exhibits enhanced apoptotic activity in hepg2 cells, Int. J. Mol. Sci., 20, 2, 10.3390/ijms20225788 Mehta, 2011, Fabrication of plant protein microspheres for encapsulation, stabilization and in vitro release of multiple anti-tuberculosis drugs, Colloids Surfaces A Physicochem. Eng. Asp., 375, 219, 10.1016/j.colsurfa.2010.12.014 Müller, 2011, Preparation and characterization of zein and zein-chitosan microspheres with great prospective of application in controlled drug release, J. Nanomater., 2011, 10.1155/2011/928728 Holt, 2013, Invited review: caseins and the casein micelle: their biological functions, structures, and behavior in foods1, J. Dairy Sci., 96, 6127, 10.3168/jds.2013-6831 Głąb, 2017, Potential of casein as a carrier for biologically active agents, Top. Curr. Chem., 375, 71, 10.1007/s41061-017-0158-z Pereira, 2014, Milk nutritional composition and its role in human health, Nutrition., 30, 619, 10.1016/j.nut.2013.10.011 M.H. ABD EL-SALAM, S. EL-SHIBINY, 2012, Formation and potential uses of milk proteins as nano delivery vehicles for nutraceuticals: a review, Int. J. Dairy Technol., 65, 13, 10.1111/j.1471-0307.2011.00737.x Graveland-Bikker, 2006, Unique milk protein based nanotubes: food and nanotechnology meet, Trends Food Sci. Technol., 17, 196, 10.1016/j.tifs.2005.12.009 Giroux, 2010, Preparation of nanoparticles from denatured whey protein by pH-cycling treatment, Food Hydrocoll., 24, 341, 10.1016/j.foodhyd.2009.10.013 Sauer, 2012, Heat stability of micellar casein concentrates as affected by temperature and pH, J. Dairy Sci., 95, 6339, 10.3168/jds.2012-5706 Semo, 2007, Casein micelle as a natural nano-capsular vehicle for nutraceuticals, Food Hydrocoll., 21, 936, 10.1016/j.foodhyd.2006.09.006 Sahu, 2008, Fluorescence study of the curcumin−casein micelle complexation and its application as a drug nanocarrier to cancer cells, Biomacromolecules., 9, 2905, 10.1021/bm800683f Shapira, 2010, Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs, Nanomed. Nanotechnol. Biol. Med., 6, 119, 10.1016/j.nano.2009.06.006 Shapira, 2010, β-casein–based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity, Nanomed. Nanotechnol. Biol. Med., 6, 547, 10.1016/j.nano.2010.01.003 Gandhi, 2019, Doxorubicin-loaded casein nanoparticles for drug delivery: preparation, characterization and in vitro evaluation, Int. J. Biol. Macromol., 121, 6, 10.1016/j.ijbiomac.2018.10.005 Penalva, 2015, Casein nanoparticles as carriers for the oral delivery of folic acid, Food Hydrocoll., 44, 399, 10.1016/j.foodhyd.2014.10.004 Elzoghby, 2013, Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics, Int. J. Nanomedicine, 8, 1721, 10.2147/IJN.S40674 Motoki, 1987, &alpha;s1-Casein Film Prepared Using Transglutaminase, Agric. Biol. Chem., 51, 993 Abu Diak, 2007, The manufacture and characterization of casein films as novel tablet coatings, Food Bioprod. Process., 85, 284, 10.1205/fbp07030 Song, 2009, Genipin-crosslinked casein hydrogels for controlled drug delivery, Int. J. Pharm., 373, 41, 10.1016/j.ijpharm.2009.02.005 Song, 2010, Novel casein hydrogels: formation, structure and controlled drug release, Colloids Surfaces B Biointerfaces., 79, 142, 10.1016/j.colsurfb.2010.03.045 Millar, 1991, Influence of sodium Caseinate on the dissolution rate of hydrochlorothiazide and Chlorothiazide, Drug Dev. Ind. Pharm., 17, 1593, 10.3109/03639049109057310 Millar, 1993, Dissolution mechanism of ibuprofen-casein compacts, Int. J. Pharm., 92, 97, 10.1016/0378-5173(93)90268-K Gubbins, 2003, The effects of casein on diclofenac release from hydroxypropylmethylcellulose (HPMC) compacts, Int. J. Pharm., 260, 69, 10.1016/S0378-5173(03)00235-7 Lambert, 2005, Evolution of the transferrin family: conservation of residues associated with iron and anion binding, Comp. Biochem. Physiol. Part B Biochem. Mol. Biol., 142, 129, 10.1016/j.cbpb.2005.07.007 Shen, 2018, Transferrin receptor 1 in cancer: a new sight for cancer therapy, Am. J. Cancer Res., 8, 916 Paterson, 2016, Exploiting transferrin receptor for delivering drugs across the blood-brain barrier, Drug Discov. Today Technol., 20, 49, 10.1016/j.ddtec.2016.07.009 Szwed, 2014, Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin, Cell. Oncol. (Dordr)., 37, 421, 10.1007/s13402-014-0205-5 Szwed, 2016, Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation, Cell. Oncol. (Dordr)., 39, 107, 10.1007/s13402-015-0256-2 Saxena, 2018, Inducing cell death in vitro in cancer cells by targeted delivery of cytochrome c via a transferrin conjugate, PLoS One, 13, 10.1371/journal.pone.0195542 Wang, 2016, Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy, Sci. Rep., 6, 27421, 10.1038/srep27421 Kim, 2010, Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides, J. Pharmacol. Exp. Ther., 334, 682, 10.1124/jpet.110.166470 Schmidt, 2013 Chen, 2011, Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins, Mol. Pharm., 8, 457, 10.1021/mp1003064 Bialasek, 2019, Exploiting iron-binding proteins for drug delivery, J. Physiol. Pharmacol., 70 Mann, 1987, Reconstituted and native iron-cores of bacterioferritin and ferritin, J. Mol. Biol., 198, 405, 10.1016/0022-2836(87)90290-7 de Turris, 2017, Humanized archaeal ferritin as a tool for cell targeted delivery, Nanoscale., 9, 647, 10.1039/C6NR07129E Pontillo, 2016, Cisplatin encapsulation within a ferritin nanocage: a high-resolution crystallographic study, Chem. Commun. (Camb)., 52, 4136, 10.1039/C5CC10365G Wang, 2017, High hydrostatic pressure encapsulation of doxorubicin in ferritin nanocages with enhanced efficiency, J. Biotechnol., 254, 34, 10.1016/j.jbiotec.2017.05.025 Fan, 2018, Ferritin nanocarrier traverses the blood brain barrier and kills Glioma, ACS Nano, 12, 4105, 10.1021/acsnano.7b06969 Liang, 2014, H-ferritin–nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection, Proc. Natl. Acad. Sci., 111, 10.1073/pnas.1407808111 Mazzucchelli, 2017, H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer, Sci. Rep., 7, 7505, 10.1038/s41598-017-07617-7 Jiang, 2019, Biomineralization synthesis of the cobalt Nanozyme in SP94-ferritin Nanocages for prognostic diagnosis of hepatocellular carcinoma, ACS Appl. Mater. Interfaces, 11, 9747, 10.1021/acsami.8b20942 Li, 2016, Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells, Biomaterials., 98, 143, 10.1016/j.biomaterials.2016.05.006